Learning outcomes
By the end of this lesson you should be able to: classify the autoimmune blistering diseases by the level of the split and by the target antigen; describe pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis and mucous membrane pemphigoid, including their direct immunofluorescence patterns and treatment; define erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis, estimate the body surface area detached and score severity; recognise the drug eruptions that matter — morbilliform, fixed drug, acute generalised exanthematous pustulosis and DRESS — and take a drug history with the correct latency window; and manage toxic epidermal necrolysis in a burns unit, including what not to do.
Prerequisites
Lesson 1 (the dermo-epidermal junction), Lesson 2 (morphology and the Nikolsky sign), Lesson 4 (herpes as a trigger of erythema multiforme and of eczema herpeticum) and Lesson 7 for pustular psoriasis.
The big idea
The second question is what antigen has been attacked: desmosomal cadherins between keratinocytes (the pemphigus group), hemidesmosomal and basement membrane proteins (the pemphigoid group), type VII collagen (epidermolysis bullosa acquisita) or epidermal transglutaminase (dermatitis herpetiformis). The first question is answered at the bedside with the Nikolsky sign and by looking at whether the mucosae are involved; the second is answered by a biopsy for H and E and a second biopsy for direct immunofluorescence — and the direct immunofluorescence must be requested on perilesional skin, because an old blister is non-diagnostic.
The intraepidermal blistering diseases
| Disease | Antigen and level | Clinical picture and diagnosis |
|---|---|---|
| Pemphigus vulgaris | IgG against desmoglein 3 (with desmoglein 1 when skin is involved); the split is suprabasal, above the basal layer | Painful oral erosions precede the skin disease in more than half of patients, followed by flaccid, fragile bullae on normal skin and large painful erosions, with a positive Nikolsky sign. Histology shows acantholysis with a row of tombstone basal cells; direct immunofluorescence gives an intercellular chicken-wire pattern of IgG and C3. Serum anti-desmoglein antibodies confirm and are quantified |
| Pemphigus foliaceus | IgG against desmoglein 1 only; a superficial granular-layer split | Scaly crusted, erythematous plaques on the scalp, face and upper trunk, with no mucosal involvement and a superficial scale; a superficial autoimmune analogue of staphylococcal scalded skin syndrome |
| Paraneoplastic pemphigus | Autoantibodies against plakins and desmogleins, associated with lymphoma, leukaemia and Castleman disease | Severe, intractable, polymorphous mucosal erosions with lichenoid and pemphigoid-like skin lesions, and often ocular and pulmonary disease; the diagnosis is a poor prognostic sign and treatment targets the tumour |
| IgA pemphigus | IgA against the epidermal cell surface | Pustules with superficial vesicles, sometimes mimicking subcorneal pustular dermatosis |
Pemphigus vulgaris is the serious one. High-dose systemic prednisolone is started immediately — 1 to 1.5 mg per kg daily, with a steroid-sparing agent such as azathioprine or mycophenolate, or rituximab as first-line therapy for moderate to severe disease. The patient needs wound care, analgesia, mouth care, nutrition, calcium and vitamin D, gastric protection, glucose monitoring, and early treatment of infection, because mortality is now driven by infection and by steroid complications rather than by the disease itself. Taper the steroids slowly and never abruptly.
The subepidermal blistering diseases
| Disease | Antigen and level | Clinical picture and diagnosis |
|---|---|---|
| Bullous pemphigoid | IgG and C3 against BP180 and BP230 of the hemidesmosome; a subepidermal split in the lamina lucida | The commonest autoimmune bullous disease: itchy urticarial plaques precede tense bullae on the abdomen, thighs and flexures in patients over 70. The Nikolsky sign is negative, eosinophilia is common, and direct immunofluorescence shows a linear band of IgG and C3 at the basement membrane. Treated with very potent topical clobetasol or oral prednisolone; often self-limiting over about 5 years |
| Mucous membrane (cicatricial) pemphigoid | Antigens of the basement membrane including BP180 and laminin 332 | Scarring erosions of the oral, ocular, pharyngeal, oesophageal and genital mucosae; the eye develops symblepharon and blindness, and needs ophthalmology care while the skin is treated |
| Dermatitis herpetiformis | Granular IgA in the dermal papillae, with antibodies against epidermal transglutaminase; a coeliac disease of the skin | Intensely itchy vesicles, always excoriated, symmetrically on the extensor surfaces of the elbows, knees, buttocks and scalp; over 90 per cent have gluten-sensitive enteropathy, usually asymptomatic, and are at risk of thyroid disease and lymphoma. Diagnosed by direct immunofluorescence of perilesional skin. Treated with dapsone for the itch and a gluten-free diet for life — and always check glucose-6-phosphate dehydrogenase and monitor haemolysis on dapsone |
| Linear IgA disease | IgA along the basement membrane | Chronic bullous disease of childhood: tense bullae in rosettes and strings of pearls around the genitalia, perioral and on the trunk. Vancomycin-induced in adults. Responds to dapsone and usually resolves |
| Epidermolysis bullosa acquisita | IgG against type VII collagen of the anchoring fibrils | Blisters in sites of trauma, scarring, milia, and association with inflammatory bowel disease; an overlap with bullous lupus erythematosus |
Drug eruptions: the history you must take
Ask about every drug started in the previous 8 weeks, including over-the-counter analgesics and antimalarials taken for fever, and note the exact date of the first symptom. The classic culprits for Stevens-Johnson syndrome and toxic epidermal necrolysis are sulfonamides including co-trimoxazole, the aromatic anticonvulsants (carbamazepine, phenytoin, lamotrigine), allopurinol, nevirapine, oxicam anti-inflammatories and thiacetazone. For DRESS they are the aromatic anticonvulsants, allopurinol and the sulfonamides. A morbilliform exanthem, by contrast, is the commonest of all drug eruptions and is usually benign, but you cannot call it benign until you have excluded those reactive syndromes and the diseases they mimic.
| Reaction | Timing and pattern | Management |
|---|---|---|
| Morbilliform (maculopapular) exanthem | 4 to 14 days after starting an ampicillin, cephalosporin, anticonvulsant or sulfonamide; the commonest reaction, and the commonest exanthem in infectious mononucleosis | Treat the itch, watch for progression, and withdraw the drug if it is not essential. Always exclude and manage the infection it may be mimicking |
| Fixed drug eruption | Hours to 2 days after re-exposure; a well-circumscribed round or oval dusky red or violaceous patch that recurs every time at the same site, then fades with striking post-inflammatory hyperpigmentation. Common on the glans, lips and hands; culprits include non-steroidal anti-inflammatory drugs, paracetamol and codeine, sulfonamides, tetracyclines, barbiturates and phenolphthalein | Stop the drug and identify it, because re-exposure reproduces the eruption within hours; the lesion resolves with pigmentation over weeks |
| Acute generalised exanthematous pustulosis (AGEP) | Hours to 2 days (about 24 hours typically) after a beta-lactam or a macrolide, but also from diltiazem, hydroxychloroquine and virus infections; high fever with numerous small, sterile, non-follicular pustules on oedematous erythema, oedema of the face, and a neutrophil leucocytosis | Withdraw the drug; the eruption resolves with desquamation over 7 to 10 days; topical corticosteroid, fluids, and no systemic immunosuppression in the typical uncomplicated patient |
| DRESS (drug reaction with eosinophilia and systemic symptoms) | 2 to 8 weeks — sometimes as long as 12 — after the first dose of carbamazepine, allopurinol, sulfonamides, abacavir, minocycline or dapsone. A morbilliform rash, facial oedema and fever with eosinophilia, hepatitis, nephritis, pneumonitis, myocarditis and thyroiditis, and reactivation of human herpesviruses 6 and 7 | Withdraw the drug, monitor liver and renal function, haemogram, cardiac enzymes and thyroid function, and treat with prednisolone 0.5 to 1 mg per kg tapered over 8 to 12 weeks. Mortality approaches 5 to 10 per cent, and autoimmune sequelae including thyroiditis and diabetes occur |
| Stevens-Johnson syndrome and toxic epidermal necrolysis | 4 to 28 days after the culprit drug; described below | Withdraw the culprit, refer to a burns or intensive care unit, and follow the protocol in Lesson 11 |
| Serum-sickness-like reaction | One to three weeks after a heterologous protein or drug, with fever, arthralgia and urticarial rash | Antihistamines, a short course of non-steroidal anti-inflammatory drugs, and withdrawal |
Erythema multiforme and the spectrum to toxic epidermal necrolysis
| Condition | Clinical picture |
|---|---|
| Erythema multiforme minor | Target (iris) lesions with three zones — a dusky centre, a pale ring and an erythematous rim — predominantly on the extensor surfaces of the limbs, hands, feet and face, arising in crops over one to two weeks and resolving in about 3 weeks. The mucosae are spared. More than 90 per cent of recurrent cases are triggered by herpes simplex; also by Mycoplasma pneumoniae and by drug exposure. Treat the trigger (long-term aciclovir for herpes, a macrolide for Mycoplasma) and support the skin |
| Erythema multiforme major / Stevens-Johnson syndrome | Mucosal erosions at two or more sites — mouth, eyes, genitals — with atypical, flat, confluent targetoid macules and limited detachment of skin; this is now understood as one end of a single spectrum with toxic epidermal necrolysis, with the drug triggers above and a delayed cytotoxic mechanism. Treated as described below |
| Toxic epidermal necrolysis | A prodrome of fever, malaise and sore throat or conjunctival injection, then painful dusky or purplish macules that coalesce and shed the epidermis in large sheets, with a positive Nikolsky sign, and detachment of more than 30 per cent of the body surface area. Mucosal involvement occurs in two-thirds. Histology shows full-thickness epidermal necrosis with a subepidermal split. Mortality is 30 to 50 per cent, and the causes of death are sepsis, multiorgan failure and respiratory involvement |
Common mistakes
Watch outTaking a drug history that stops at the prescription list in front of you. Severe cutaneous adverse reactions depend on drugs started 2 to 8 weeks ago, and on over-the-counter ones. Ask the patient what they have taken in the last two months and at what date each was started, and mark the first day of symptoms, because that is the only way to identify the culprit.
Watch outRequesting direct immunofluorescence from an old blister. Direct immunofluorescence requires perilesional, non-blistered skin — from the edge of a lesion, or from adjacent normal skin. A crusted old blister is an uninterpretable specimen and will report as negative.
Watch outAssuming every blistering eruption is an infection. A Bullous eruption in an older adult with an urticarial prodrome is bullous pemphigoid, and in a younger adult with oral erosions it is pemphigus vulgaris; an infected blister is pus-filled and painful, whereas autoimmune bullae are tense and clear. Conversely, an itchy excoriated blistering eruption is scabies until proven otherwise.
Watch outGiving blistering skin to topical and systemic steroids as if that were treatment. Pemphigus vulgaris needs high-dose systemic therapy, bullous pemphigoid often very potent topical therapy, and toxic epidermal necrolysis needs supportive care and generally no systemic steroid. Each is different, and applying a single reflex is dangerous.
Check your understanding
Why must a biopsy for direct immunofluorescence be taken from perilesional skin, and what does a false-negative specimen look like?
Multiple choice
Which statement about the level of the split in autoimmune blistering disease is correct?
A patient of 74 has intensely itchy excoriated vesicles on the extensor surfaces of the elbows and knees and is anaemic. Which disease is most likely, and what treatment helps both the rash and the underlying enteropathy?
A patient develops a fever with a widespread rash, facial oedema, eosinophilia and raised transaminases six weeks after starting carbamazepine. Which reaction has occurred, and what is the main risk?
Which drug is a recognised cause of Stevens-Johnson syndrome and toxic epidermal necrolysis?
Summary and next
Blistering disease is classified by the level of the split and by the antigen. Pemphigus vulgaris splits within the epidermis against desmoglein 3, starts with painful oral erosions and needs systemic immunosuppression; bullous pemphigoid splits below the membrane against BP180 in the elderly and is treated with very potent topical steroid; dermatitis herpetiformis is IgA in the papillae, extensor, excoriated and gluten dependent. Drug eruptions are diagnosed from the latency window — 4 to 28 days for Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS — and drug eruptions distinguish by the treatment they forbid, above all in toxic epidermal necrolysis, where the drug must be stopped, the skin is managed like a major burn, and systemic corticosteroids are avoided.
Next: the pigmentary disorders. Melanocyte biology, vitiligo, melasma and post-inflammatory pigment change, and the difference between the depigmented macule that will not respond and the hypopigmented one that will.